Catheter-Related Early Thromboprophylaxis With Enoxaparin (CRETE) Trial
Status:
Terminated
Trial end date:
2019-08-16
Target enrollment:
Participant gender:
Summary
The purpose of this phase 2a, multi-center, randomized controlled study, is to explore the
efficacy of early prophylaxis against catheter-associated deep venous thrombosis (CADVT) in
critically ill children.
Phase:
Phase 2
Details
Lead Sponsor:
Yale University
Collaborators:
Children's Hospital and Health System Foundation, Wisconsin Dell Children's Medical Center of Central Texas Dell Children’s Medical Center of Central Texas Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) Maria Fareri Children's Hospital St. Louis Children's Hospital University of Rochester Golisano Children's Hospital Weill Medical College of Cornell University